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Abstract
Vitamin D is implicated in a wide range of health outcomes, and although environmental predictors of vitamin D levels
are known, the genetic drivers of vitamin D status remain to be clarified. African Americans are a group at particularly
high risk for vitamin D insufficiency but to date have been virtually absent from studies of genetic predictors of
circulating vitamin D levels. Within the Southern Community Cohort Study, we investigated the association between 94
single nucleotide polymorphisms (SNPs) in five vitamin D pathway genes (GC, VDR, CYP2R1, CYP24A1, CYP27B1)a n d
serum 25-hydroxyvitamin D (25(OH)D) levels among 379 African American and 379 Caucasian participants. We found
statistically significant associations with three SNPs (rs2298849 and rs2282679 in the GC gene, and rs10877012 in the
CYP27B1 gene), although only for African Americans. A genotype score, representing the number of risk alleles across the
three SNPs, alone accounted for 4.6% of the variation in serum vitamin D among African Americans. A genotype score of
5 (vs. 1) was also associated with a 7.1 ng/mL reduction in serum 25(OH)D levels and a six-fold risk of vitamin D
insufficiency (,20 ng/mL) (odds ratio 6.0, p=0.01) among African Americans. With African ancestry determined from a
panel of 276 ancestry informative SNPs, we found that high risk genotypes did not cluster among those with higher
African ancestry. This study is one of the first to investigate common genetic variation in relation to vitamin D levels in
African Americans, and the first to evaluate how vitamin D-associated genotypes vary in relation to African ancestry.
These results suggest that further evaluation of genetic contributors to vitamin D status among African Americans may
help provide insights regarding racial health disparities or enable the identification of subgroups especially in need of
vitamin D-related interventions.
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Introduction
External exposures (sunlight, diet, and vitamin supplements) are
chief determinants of circulating 25-hydroxyvitamin D (25(OH)D),
the established clinical marker of vitamin D status [1]. However,
with several genes controlling pathways that synthesize, transport,
and degrade forms of vitamin D, common genetic variants may
also play a role in individual (and potentially population)
differences in vitamin D status. It is increasingly appreciated that
vitamin D status is to some extent under genetic control [2], and
that the heritability of vitamin D levels may be greater than
previously assumed [3–7]. With vitamin D implicated in a wide
range of health issues from rickets to cancer [8,9], a fuller
understanding of the determinants of vitamin D status is needed
and must include consideration of inherited characteristics.
The group-specific complement gene (GC) on chromosome 4
encodes the vitamin D binding protein (VDBP) that is the main
transporter of vitamin D and its metabolites in the circulation
[10]. Evidence is accumulating that polymorphisms in the GC
gene are associated with circulating 25(OH)D levels [2].
Recently, two genome-wide association studies (GWAS) of
25(OH)D levels in populations of European ancestry found
strong evidence for an association with a single nucleotide
polymorphism (SNP) in GC (rs2282679 in intron 12) [11,12]. The
GC SNPs rs7041 and rs4588 in exon 11 have also been the
subject of much attention in the literature [7,13–19]. Studies are
now evaluating the independent or 25(OH)D-effect-modifying
association between GC SNPs and disease outcomes [14,17–
19,20–23]. In addition, there are several other vitamin D
pathway genes (e.g., CYP27B1, CYP24A1, CYP2R1, VDR)t h a t
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have been less studied.
African Americans have considerably lower average 25(OH)D
levels than Caucasians in the United States, with a prevalence of
vitamin D insufficiency reported in the range of 40–80% [24–29].
We have previously reported on racial differences in vitamin D
status [24] and recently found novel associations between the
degree of African ancestry and serum 25(OH)D levels among
African Americans in the Southern Community Cohort Study
(SCCS), for which explanations beyond possible skin color
gradations should be explored [30]. Although there is racial
variation in the GC gene [10,31], to date the association between
GC gene polymorphisms and 25(OH)D has been studied, with few
exceptions [7,32], almost exclusively in populations of European
descent [11–13,16,20,33]. We therefore undertook a study to
investigate (1) whether and to what extent genetic polymorphisms
in GC, CYP27B1, CYP24A1, CYP2R1, and VDR determine
25(OH)D levels in African Americans and Caucasians; and (2)
whether polymorphisms in these genes mediate the association
between African ancestry and 25(OH)D levels among African
Americans that we previously reported [30].
Results
Characteristics of the study population are presented in Table 1.
African Americans had lower mean serum 25(OH)D levels
(17.5 ng/mL, 95%CI 16.6–18.4 ng/mL) than Caucasians
(27.2 ng/mL, 95%CI 26.1–28.3 ng/mL). The enrollment of
African Americans and Caucasians from the same community
health centers year-round resulted in only minor differences in
residential ultraviolet radiation (UVR) scores and season of
enrollment by race.
The SNPs rs222054 in the GC gene and rs12314197 in the VDR
gene deviated from HWE for Caucasians, and these data were
dropped from the study. The remaining SNP genotype frequencies
and mean serum 25(OH)D levels by genotype among African
American and Caucasian subjects are presented in Table S1, with
the significant results shown in Table 2. Three SNPs were
significantly associated with 25(OH)D, but only among African
Americans. Two of the SNPs, rs2298849 and rs2282679, were in
the GC gene but not in LD with each other (r
2=0.01 in YRI and
0.08 in CEU) and one was in the CYP27B1 gene (rs10877012).
The reference allele frequencies for these SNPs in our African
American and Caucasian study groups were very similar to those
reported in HapMap for the YRI and CEU populations,
respectively (not shown).
The three identified SNPs were then modeled to estimate the
effect of each high risk genotype (Table 3). These analyses showed
that variation in each SNP was associated with average 25(OH)D
changes of 2.1 to 3.6 ng/mL. When the three SNPs were included
in the same model, only rs2298849 retained statistical significance,
with the AA genotype associated with an average decrease in
serum 25(OH)D of 3.3 ng/mL compared to the GG genotype.
A genotype score was constructed as the sum of the number of
G alleles for rs2282679, A alleles for rs2298849, and G alleles for
rs10877012 (i.e., a sum of the risk alleles). The range of the
genotype score was 1–5 for African Americans and 1–6 for
Caucasians. This score was strongly and significantly related to
25(OH)D levels among African Americans (Figure 1) but not
among Caucasians (not shown). African Americans with a score of
5 had mean serum vitamin D levels 7.1 ng/mL lower than those
with a score of 1, and the trend across the score was highly
significant (ptrend,0.001). In addition, those with scores 2, 3, 4, and
5 (compared to 1) were at progressively increased risk for vitamin
D insufficiency: OR=1.35 (p=0.56), 2.67 (p=0.05), 2.54
(p=0.06), and 6.01 (p=0.01), respectively.
Among African Americans, we examined how high risk
genotypes for the three SNPs were distributed across tertiles of
African ancestry. Overall, we observed that the high risk genotypes
for rs2298849, rs2282679, and rs110877012 did not cluster among
those of higher African ancestry and so would not seem to predict
(on their own) an association between higher African ancestry and
lower vitamin D levels (Table 4). Those in the highest tertile of
African ancestry were even significantly less likely (p=0.003) to
have the high risk genotype for rs2282679. The average genotype
score also varied little across tertiles of African ancestry (3.1–3.2),
Table 1. Serum 25(OH)D levels and other related characteristics for 758 African American and Caucasian SCCS participants.
Characteristic African American (N=379) Caucasian (N=379)
Number of females/males 187/192 187/192
Mean (range) percentage African ancestry 0.929 (0.505,0.999) 0.009 (0.001,0.171)
Mean (range) percentage European ancestry 0.071 (0.001,0.495) 0.991 (0.829,0.999)
Mean (S.D.) serum 25(OH)D levels, ng/mL 17.5 (8.6) 27.2 (11.1)
Mean (S.D.) age, years 51.9 (9.0) 54.1 (9.5)
Mean (S.D.) body mass index
a,k g / m
2 28.3 (5.6) 28.4 (5.8)
Mean (S.D.) daily dietary intake of vitamin D
b, IU 218 (213) 269 (236)
Mean (S.D.) residential UVR score 5.2 (1.9) 5.2 (2.0)
% enrolled in winter
c 17% 22%
% enrolled in spring
c 30% 27%
% enrolled in summer
c 25% 26%
% enrolled in fall
c 28% 25%
% current smoker
a 34% 34%
Abbreviations: SCCS, Southern Community Cohort Study; S.D., standard deviation; IU, International Units; UVR, ultraviolet radiation.
aSelection/matching factor.
bFrom food sources and multivitamin and calcium supplement sources.
cWinter: December-February; Spring: March-May; Summer: June-August; Fall: September-November.
doi:10.1371/journal.pone.0028623.t001
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increase in African ancestry, genotype score remained virtually
unchanged (b=+0.008, p=0.89).
A linear regression model restricted to African Americans, with
covariates for dietary vitamin D intake, UVR score, age, body
mass index, smoking, sex, and percentage African ancestry
accounted for 26% of the variation in 25(OH)D levels (model
R
2=0.259). The addition of the genotype score increased the
model R
2 to 0.285, indicating these three SNPs accounted for a
10.0% relative increase in the model’s ability to explain variation
in 25(OH)D. A likelihood ratio test comparing the two models was
also statistically significant (p=0.02), indicating that the genotype
score significantly increased the model’s explanatory power for
African Americans. Among Caucasians, the addition of the
genotype score to a model including the same environmental
determinants also increased the model R
2 from 0.176 to 0.193,
although the likelihood ratio test comparing the two models was
not statistically significant (p=0.22).
Discussion
Although the heritability of vitamin D status appears
considerable [3–7], the specific genetic determinants of vitamin
D levels are only beginning to be identified. Herein, in one of the
first studies of genetic determinants of 25(OH)D levels involving
African Americans, we found significant associations with three
SNPs in vitamin D pathway genes, all of which replicate earlier
findings in populations of European ancestry (rs2282679
[11,12,20], rs2298849 [33], rs10877012 [34,35]). Importantly,
included among these was rs2282679, a highly significant result
from two recent GWAS [11,12], one of which reported a 49%
increased risk for vitamin D insufficiency (,20 ng/mL) associ-
ated with the rs2282679 minor allele among Caucasians [12].
Among African Americans, we found the risk of vitamin D
insufficiency associated with the GT or GG genotype for
rs2282679 to be similarly elevated (OR=1.70) although not
statistically significant (p=0.12). It is notable that we found no
significant associations for Caucasians in our study, the size of
which was relatively small, and power limitations might explain
why we failed to detect a signal among Caucasians. Because
African Americans have lower baseline levels of 25(OH)D than
Caucasians and may not benefit equally from sunlight-mediated
vitamin D synthesis due to heavy skin melanization, genetic
influences on 25(OH)D may be relatively more important in
determining overall vitamin D status among African Americans
and easier to detect in smaller studies. The only previous study of
genetic predictors of 25(OH)D among African Americans
involved 513 African Americans from 42 families in Los Angeles,
CA, and evaluated 30 SNPs in GC, VDR,a n dCYP27B1 [7].
Although the examined SNPs included two of the three for which
we found an association (rs2298849 and rs10877012), significant
findings were reported only for the GC SNPs rs7041 and rs4588
[7].
Table 2. Single nucleotide polymorphisms (SNPs) significantly associated with serum 25(OH)D levels.
Gene dbSNP ID Chr Position
a African Americans (N=379) Caucasians (N=379)
Homozygous
referent (HR),
Heterozygous
(HET),
Homozygous
variant (HV)
a
(Ni n
parentheses)
Mean serum
25(OH)D, ng/mL p-value
b
Homozygous
referent (HR),
Heterozygous
(HET),
Homozygous
variant (HV)
a
(Ni n
parentheses)
Mean serum
25(OH)D, ng/mL p-value
b
HR HET HV HR HET HV
GC rs2298849 4 72867715 AA (139), AG
(172), GG (61)
16.4 17.5 20.4 0.008 AA (240), AG
(120), GG (10)
27.1 27.0 27.3 0.97
rs2282679 4 72827247 TT (317),
GT (57), GG (1)
17.7 15.5 9.4 0.03 TT (199), GT
(150), GG (26)
27.5 27.0 26.9 0.66
CYP27B1 rs10877012 12 56448352 GG (291),
GT (82), TT (3)
16.9 18.9 26.5 0.02 GG (188), GT
(161), TT (27)
27.3 27.0 28.0 0.99
aBase position on chromosome (Chr) and allele naming of each single nucleotide polymorphism (SNP) are based on forward strand according to human genome
assembly 18 (March 2006, NCBI Build 36.1).
bp-value for the association between the SNP genotypes (parameterized as 0/1/2, for HR/HET/HV, respectively) and 25(OH)D levels from race-stratified linear regression
models adjusted for sex and level of African ancestry.
doi:10.1371/journal.pone.0028623.t002
Table 3. Linear regression-derived associations between
rs2298849, rs2282679, and rs10877012 and serum levels of
25(OH)D among African Americans.
SNP Comparison beta
a p-value
Model type 1
b
rs2298849 AA to GG 23.62 0.005
rs2282679 (GT, GG combined
c)t oT T 22.53 0.03
rs10877012 GG to (GT, TT combined
c) 22.11 0.04
Model type 2
d
rs2298849 AA to GG 23.27 0.01
rs2282679 (GT, GG combined
c)t oT T 21.87 0.13
rs10877012 GG to (GT, TT combined
c) 21.40 0.18
aInterpreted as the average change in serum 25(OH)D level (ng/mL) associated
with the genotype comparison shown in the table.
bThree separate linear regression models including each SNP alone, adjusted for
sex and percentage African ancestry.
cGenotypes combined because less than five subjects had the homozygous
variant genotype.
dOne linear regression model including the three SNPs together, adjusted for
sex and percentage African ancestry.
doi:10.1371/journal.pone.0028623.t003
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outdoors, latitude, leisure time physical activity), diet, and other
characteristics (e.g., age, adiposity, self-reported race, smoking,
alcohol drinking) have been shown to account for about 20–40%
of the variability in circulating 25(OH)D [3,7,13,24,26,36,37]. To
date, the estimated contribution of several identified SNPs to
variation in 25(OH)D is generally less than 5% [11–13], although
with further investigation this should increase. Among African
Americans in our study, the genotype score based on three SNPs
alone could account for 4.6% of the variation in 25(OH)D,
whereas UVR score alone could account for 11.9% and diet 4.8%.
It is important to note that the highest genotype score among
African Americans was associated with an average reduction in
serum 25(OH)D of 7.1 ng/mL; in context, this is not trivial given
that mean serum 25(OH)D levels among African Americans are
typically in the range of 10–20 ng/mL [7,24–28].
We previously reported that, among African Americans, serum
25(OH)D levels decreased 1.0 ng/mL with each 10% increase in
African ancestry [30]. We did not find evidence in this analysis,
however, that the SNPs examined would account for these
findings. Of the three SNPs that were associated with vitamin D
levels, African Americans across the spectrum of ancestry had
similar genotypes. This was contrary to our expectation that
genotypes associated with the lowest 25(OH)D levels might be
more common in individuals with the highest African ancestry.
Our earlier findings may be a result of genetic variation not
captured in this specific analysis, or skin color gradations along the
spectrum of African ancestry, or both.
Our study is one of the first evaluations in African Americans of
genetic determinants of vitamin D levels, and to our knowledge the
first to evaluate how genotypes associated with vitamin D status
vary in relation to African ancestry. Another strength of this
Figure 1. Genotype score in relation to serum 25(OH)D levels among African Americans. Plot of the estimated, average decrease in serum
level of 25(OH)D (y-axis) in relation to genotype score (x-axis). Genotype score equals the sum of the number of risk alleles (i.e., A for rs2298849, G for
rs2282679, and G for rs10877012). Estimates were derived from a linear regression model restricted to African Americans, using a genotype score of 1
as a referent, and including covariates for sex and level of African ancestry.
doi:10.1371/journal.pone.0028623.g001
Table 4. Association between level of African Ancestry and genotypes of rs2298849, rs2282679, and rs10877012 among African
Americans.
Frequency of high risk genotype
a (%)
Lowest tertile
African ancestry
Middle tertile
African ancestry
Highest tertile
African ancestry p-value
b
High risk genotype
a
AA (rs2298849) 38% 39% 35% 0.83
GG or GT
c (rs2282679) 21% 19% 7% 0.003
GG (rs10877012) 74% 79% 79% 0.50
Mean (S.D.) genotype score 3.1 (1.1) 3.2 (1.0) 3.1 (0.9)
aGenotype associated with the lowest 25(OH)D levels in our data.
bp-value from Pearson’s chi square test comparing proportions across the three ancestry groups.
cGenotypes combined because less than five subjects had the homozygous variant genotype.
doi:10.1371/journal.pone.0028623.t004
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patient groups. One limitation of the study is our reliance on a
single measurement of 25(OH)D as representative of the subjects’
general vitamin D status. However, in a separate analysis of 225
SCCS participants who provided two blood samples 1 to 3 years
apart, we found a very high correlation (r=0.91, p,0.001)
between the two measured 25(OH)D levels (unpublished). The
small size of our study and the lack of a replication group are
additional limitations, and it will be important to seek replication
of these findings in larger samples of African Americans.
In conclusion, we found that common genetic variation does
play a role in determining 25(OH)D levels in African Americans,
and we were able to replicate key recent findings regarding GC and
CYP27B1 SNPs reported from populations of European descent,
which were paradoxically not evident in our Caucasian study
group. Establishing a genetic underpinning of vitamin D levels
among African Americans who are at particularly high risk for
vitamin D deficiency would be an important advancement in our
understanding of the drivers of vitamin D status and may provide
further insights into the causes of certain racial health disparities.
As the current body of work moves forward, it will be important to
include discovery stage GWAS and larger candidate gene studies
among African Americans. Such work may enable the identifica-
tion of subgroups of African Americans especially in need of
vitamin D-related interventions.
Materials and Methods
Ethics statement
SCCS participants provided written informed consent, and
protocols were approved by Institutional Review Boards at
Vanderbilt University and Meharry Medical College.
Study population
The SCCS is a prospective cohort study of cancer risk
disparities related to race, socioeconomic status, and other factors.
Men and women aged 40–79 were enrolled across 12 southeastern
US states between 2002 and 2009, largely by in-person
recruitment at community health centers [38]. With approxi-
mately 86,000 participants enrolled, African Americans comprise
two-thirds of the cohort. For the analyses herein, from SCCS
participants who enrolled from March 2002–October 2004 and
donated a baseline blood sample (N=12,162), 792 were randomly
selected using a 2626363 factorial design, with 22 individuals
selected within each of the 36 strata defined by self-reported race
(African American/non-Hispanic white), sex, smoking status
(current former never), and body mass index (BMI, 18–
24.99 kgm
2, 25–29.99 kgm
2, 30–45 kgm
2). This design provided
a balanced distribution across these factors which allowed for
racial comparisons unconfounded by sex, smoking, and BMI, and
avoided a population heavily enriched with current smokers and
obese individuals (as obesity and current smoking is highly
prevalent in the cohort).
Baseline data and blood collection
Baseline data were collected using a computer-assisted, in-
person interview conducted at the time of enrollment. The
interview covered demographics, health history, anthropometrics,
diet, and a wide range of potential cancer risk factors
(questionnaire available at www.southerncommunitystudy.org).
Dietary information was collected using a validated food frequency
questionnaire developed specifically for the SCCS [39,40]. Venous
blood samples (20 mL) were collected during the baseline
interview within the community health center, kept refrigerated
and shipped cold overnight to Vanderbilt University where they
were centrifuged the next day and stored at 280uC to await
analysis.
SNP Selection and Genotyping
For VDR genotyping (completed in 2008), the Caucasian (CEU)
and African (YRI) populations in the International HapMap
project were the primary data source for the selection of tagging
SNPs [41]. These SNPs were selected to cover variants based on a
linkage disequilibrium (LD) parameter of r
2.0.8 in the VDR gene
610 kb and a minor allele frequency (MAF) $0.05 for either the
CEU or YRI populations. Functional SNPs were forced into the
selection process. Three separate sets of SNPs were grouped as
those tagging Caucasians only, those tagging Africans only, and
those tagging both populations. All SNPs were scored for the
ability to perform well on the Illumina GoldenGate genotyping
platform using an Illumina in-house algorithm (Illumina Inc., San
Diego, CA). The LDSelect algorithm was then run separately for
the CEU and YRI data using an r
2 cut-off of 0.8 [42]. When
multiple tagging SNPs were found for an LD bin, those SNPs
designated as tagging SNPs in both populations were preferentially
selected for efficiency. Fifty-nine SNPs were thus selected for the
VDR gene.
For GC (genotyped in 2010 along with CYP2R1, CYP24A1, and
CYP27B) tagging SNPs were selected by analyzing the HapMap
II+III genotype data (release 27) from CEU or YRI populations
using the pairwise algorithm of Tagger function [43] implemented
in HaploView version 4 [44]. These tagging SNPs covered
variants based on an LD parameter of r
2.0.8 in the GC gene
65 kb and a MAF $0.05 for either CEU or YRI. Literature-
reported or potentially functional SNPs in GC were forced into the
SNP selection process. Thirty-seven SNPs were thus selected for
the GC gene. We also selected 11 SNPs in CYP2R1, CYP24A1, and
CYP27B1 solely based on their reported associations with
25(OH)D in other populations (CYP2R1: rs10500804, rs1562902,
rs10741657, rs10766197, rs2060793; CYP24A1: rs17219315,
rs2244719, rs2296241; CYP27B1: rs10877012, rs4646536,
rs703842) [11,33–35,45–47].
Genomic DNA was extracted from buffy coat using Qiagen’s
DNA purification kits (Qiagen, Valencia, CA) according to the
manufacturer’s instructions, and genotyping was carried out at
Vanderbilt University using the Illumina GoldenGate genotyping
platform (Illumina Inc., San Diego, CA) for the VDR gene and the
Sequenom MassARRAY system (Sequenom, San Diego, CA) and
TaqMan assays (Applied Biosystems, Carlsbad, CA) for the GC,
CYP2R1, CYP24A1, and CYP27B1 genes.
For VDR, 12 SNPs were excluded due to call rates ,95%,
leaving 47 SNPs for analysis. Blinded QC samples (N=29) and
another 171 pairs of duplicated samples were included in this
genotyping run and the consistency rate was 99.9%. For GC,
CYP2R1, CYP24A1, and CYP27B1, 47 of the 48 selected SNPs
were designed in two Sequenom assays (29 and 18 SNPs,
respectively) using the MassARRAY Assay Design 4.0 software,
and 42 SNPs were successfully genotyped using the MassARRAY
system (Sequenom, San Diego, CA) with call rates .97%.
Genotype concordance of 36 pairs of duplicated samples was
100% and was 96.5%–100% (average 99.8%) for the 75 HapMap
samples comparing genotyping data obtained from the current
study with data obtained from the HapMap project. Genotypes of
two SNPs (rs222054, rs1491719) which failed in the MassARRAY
assay were imputed using IMPUTE2 [48], with the corresponding
YRI or CEU HapMap phased haplotypes (release 22, build 36) as
a reference panel. The imputation quality was very high for both
SNPs, with probabilities for rs222054 and rs1491719 in African
Genetic Determinants of Serum 25(OH)D
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Caucasians 97.0% and 99.5%, respectively. Three additional
SNPs that failed in MassARRAY assays (rs4588, rs2282679,
rs155563) were genotyped using a TaqMan assay on a PRISM
7900HT Sequence Detector (Applied Biosystems, Carlsbad, CA).
Call rates for these three SNPs ranged from 95.6% to 99.9%; the
concordance rates were 100% for the 36 blinded duplicate samples
and for the 75 HapMap samples comparing genotyping data
obtained from the current study with data obtained from the
HapMap project. One SNP in the CYP27B1 gene (rs703842) failed
in both Sequenom MassARRAY and Taqman assays and could
not be imputed well for African Americans, and thus was dropped
from the study.
Ancestry estimation
A set of 276 ancestry informative SNPs compiled as described
previously [30] allowed the estimation of African and European
ancestry using a Bayesian clustering approach implemented using
STRUCTURE software, version 2.2.3. [49,50].
Measurement of serum 25(OH)D and external sources of
vitamin D
Blinded serum 25(OH)D measurements were performed at the
Medical University of South Carolina using a radioimmunoassay
method associated with high intra-assay reliability [51]. In our
study samples, the coefficients of variation on duplicate, blinded
quality control samples in two batches were 6.7% and 7.4%.
Dietary intake of vitamin D was estimated from the reported
intake of the major food sources from the SCCS food frequency
questionnaire: milk, cold cereal, tuna, eggs, multivitamins and
calcium supplements. Individual measures of sun exposure were
not available. However, as a surrogate we used ground ultraviolet
radiation (UVR) measurements from the National Oceanic and
Atmospheric Administration UV station geographically closest to
the subject’s residence (http:www.cpc.ncep.noaa.govproductsstra-
tosphereuv_index). These UVR measurements are converted to
an index that estimates the erythemal intensity, with scores
ranging from 0 (none) to 11+ (extreme). We used the average of
the UVR scores recorded at the monitoring station during the 3-
month period preceding each participant’s enrollment in the
study, which we have previously shown to be highly correlated
with SCCS participant serum 25(OH)D levels [24].
Statistical Analysis
Of the 792 subjects selected for this study, 34 (4.3%) were
excluded because either 25(OH)D could not be measured,
genotyping could not be performed, or ancestry estimates were
highly discordant with self-reported race. This left 758 subjects
(379 African American, 379 Caucasian) for analysis.
Mean serum 25(OH)D values were computed for African
American and Caucasian participants within each group of
homozygous referent (HR), heterozygous (HET), and homozygous
variant (HV) genotype for each SNP. HR was selected to be the
most common race-specific homozygous genotype. The associa-
tion between genotype and serum 25(OH)D level was first
evaluated by linear regression analyses that modeled 25(OH)D
as the dependent variable and genotype (i.e., with values of 0 for
HR, 1 for HET, and 2 for HV) as the independent variable, with
adjustment for sex and percentage African ancestry to account for
potential population stratification [52]. In cases where less than 10
subjects were HV or HET combined, regression analysis was not
performed. Szroeter’s rank test for heteroskedasticity and normal
probability plots of the residuals indicated that transformation of
25(OH)D in the regression models was not required.
For the 18 candidate SNPs identified from the literature (see
footnotes to Table S1), a p-value cutoff of 0.05 was used to
determine statistical significance for an association with 25(OH)D.
For the tagging SNPs chosen for GC and VDR, in order to
maintain a familywise a error level of 0.05, a Bonferroni
correction was made based on 30 comparisons for GC and 47
for VDR (under the assumption that each gene represents a
separate hypothesis [53]), resulting in p-value cutoffs of 1.66610
23
and 1.06610
23, respectively, denoting statistical significance.
Testing for HWE for each SNP in African Americans and
Caucasians was carried out using PLINK software [54].
SNPs found to be significantly associated with serum levels of
25(OH)D were examined in more detail as described below using
a codominant inheritance model with indicator variables for each
genotype unless fewer than 5 subjects were HV, in which case a
dominant model was used that combined subjects with HV and
HET.
We assessed whether genotypes associated with 25(OH)D levels
varied in relation to African ancestry by calculating their
frequency across strata defined by tertiles of African ancestry.
We also assessed the predictive value of genetic factors on
circulating 25(OH)D levels by comparing regression models with
environmental predictors of 25(OH)D (UVR score, dietary intake
of vitamin D, sex, age, African ancestry, body mass index, and
smoking) with and without the SNP data. UVR score was favored
as a covariate over season of blood collection, because the UVR
score is informative for season as well as geographical location.
To evaluate the potential combined effects of SNPs identified as
being significantly associated with serum 25(OH)D, a genotype
score approach was used [12] where the score was equal to the
sum of the number of risk alleles across the SNPs. The genotype
score was evaluated in relation to serum 25(OH)D levels as well as
to the risk of vitamin D insufficiency, which was defined as a serum
25(OH)D level below 20 ng/mL [9]. Odds ratios (OR) and 95%
confidence intervals (CI) for vitamin D insufficiency were
estimated using unconditional logistic regression models adjusted
for sex and African ancestry.
Supporting Information
Table S1 Genotype frequency for SNPs in GC, VDR,
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